Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension

Journal of Hypertension

Volumn 20, Issue 7, 2002, Pages 1335-1345

  O'Connor, Daniel T ^a   Kailasam, Mala T ^a   Kennedy, Brian P ^a   Ziegler, Michael G ^a   Yanaihara, Noboru ^a   Parmer, Robert J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Catecholamine; Catestatin; Chromaffin; Chromogranin; Ethnicity; Heredity; Hypertension; Leptin; Nicotinic cholinergic receptor

Indexed keywords

ADRENALIN; CATESTATIN; CHROMOGRANIN A; LEPTIN; NICOTINIC RECEPTOR; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; CATECHOLAMINE; CHROMOGRANIN; CHROMOGRANIN A (344 364); CHROMOGRANIN A (344-364); PEPTIDE FRAGMENT;

ADRENALIN RELEASE; ADRENERGIC SYSTEM; ADULT; ARTICLE; BODY MASS; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; COLD STRESS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENETIC PREDISPOSITION; GENETIC RISK; HEMODYNAMICS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRESSOR RESPONSE; PRIORITY JOURNAL; PROGENY; RACE; RADIOIMMUNOASSAY; VASCULAR RESISTANCE; BLOOD; CLINICAL TRIAL; COLD; COMPARATIVE STUDY; ETHNOLOGY; GENETIC MARKER; GENETICS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PREDICTION AND FORECASTING; STATISTICS; STRESS; TIME; UNITED STATES;

ADULT; CALIFORNIA; CATECHOLAMINES; CHROMOGRANIN A; CHROMOGRANINS; COLD; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; LEPTIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; STATISTICS; STRESS; TIME FACTORS;

EID: 0036628754     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200207000-00020     Document Type: Article

References (48)

1. Genetic factors, family history, and blood pressure
2. Familial aggregation and genetic epidemiology of blood pressure
3. Genetic dissection of complex traits
4. Molecular genetics of human hypertension
5. Heredity and the autonomic nervous system in human hypertension
6. Hereditary intermediate phenotypes in African-American hypertension
7. Multigenic human hypertension: Evidence for subtypes and hope for haplotypes
8. Expression of altered alpha 2-adrengeric phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension
9. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
10. Novel autocrine feedback control of catecholamine release: A discrete chromogranin A fragment is a non-competitive nicotinic cholinergic antagonist
11. The autonomic nervous system and catecholamines in normal blood pressure control and in hypertension
12. Elevated total norepinephrine spillover in normotensive members of hypertensive families
13. Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?
14. Region-specific radioimmunoassay for human chromogranin A
15. Application of region-specific immunoassay for human chromogranin A: Substantial clue for detection and measurement of chromogranin A in human plasma
16. Rapid radioimmunoassay of circulating chromogranin A: In vitro stability, exploration of the neuroendocrine character of neoplasia, and assessment of the effects of organ failure
17. Chromogranin A in human hypertension: Influence of heredity
18. Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension
19. Leptin-much more than a satiety signal
20. Regulation of metabolism and body fat mass by leptin
21. Regulation of leptin production in humans
22. Leptin
23. Baroreflex sensitivity and heredity in essential hypertension
24. Effect of positive family history of hypertension on the blood pressure and catecholamine responses to a 6-hour adrenaline infusion
25. Pressor response to norepinephrine in essential hypertension: A study in families
26. Chromogranin A: Storage and release in hypertension
27. Formation of the catecholamine release-inhibitory peptide catestatin from chromogranin A: Determination of cleavage sites in hormone storage granules
28. 344-364) acts at the receptor to prevent nicotinic cholinergic tolerance
29. 344-364): Identification of amino acid residues crucial for activity
30. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo
31. Autonomic function in hypertension: Are there racial differences?
32. Race and gender comparisons: I. Hemodynamic responses to a series of stressors
33. Race and gender comparisons: II. Predictions of work blood pressure from laboratory baseline and cardiovascular reactivity measures
34. Circulating amylin in human essential hypertension: Heritability and early increase in subjects at genetic risk
35. Obesity-hypertension: The effects on cardiovascular and renal systems
36. Obesity - A genetic disease of adipose tissue?
37. Monogenic disorders of obesity and body fat distribution
38. Leptin directly stimulates catecholamine secretion and synthesis in cultured porcine adrenal medullary chromaffin cells
39. Ca(2+) mobilization, tyrosine hydroxylase activity, and signaling mechanisms in cultured porcine adrenal medullary chromaffin cells: Effects of leptin
40. State-of-the-art-lecture: Obesity-induced hypertension: New concepts from the emerging biology of obesity
41. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure
42. Interaction between leptin and sympathetic nervous system activity in hypertension
43. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
44. Attenuation of the polypeptide 7B2, prohormone convertase PC2, and vasopressin in the hypothalamus of some Prader-Willi patients: Indications for a processing defect
45. Monogenic disorders of obesity and body fat distribution
46. The role of the sympathetic nervous system in regulation of leptin synthesis in C57BL/6 mice
47. Activation of beta-3 adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice